共 156 条
[21]
Ellis LM(2004)Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337-4713
[22]
Ellis V(2010)Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer J Clin Oncol 28 4706-2048
[23]
Pollock R(2007)Cetuximab for the treatment of colorectal cancer N Engl J Med. 357 2040-1664
[24]
Broglio KR(2007)Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer J Clin Oncol 25 1658-312
[25]
Nordlinger B(2013)CORRECT Study Group. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Lancet 381 303-327
[26]
Sorbye H(2013)Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies Cancer Treat Rev 39 321-undefined
[27]
Glimelius B(undefined)undefined undefined undefined undefined-undefined
[28]
Poston GJ(undefined)undefined undefined undefined undefined-undefined
[29]
Schlag PM(undefined)undefined undefined undefined undefined-undefined
[30]
Rougier P(undefined)undefined undefined undefined undefined-undefined